How hot is the investment in the robot industry in 2021?

　　According to relevant statistics, in the first 11 months of this year alone, 316 robotics projects have received financing with a total amount of over 33.05 billion yuan, which will reach 36 billion yuan in the whole year, with an average of over 100 million yuan per financing.

　　Since the beginning of this year, medical robots in various categories such as collaboration, surgery, warehousing, service, cleaning, and industry have blossomed, and companies are rushing to invest in the regular robot industry.

　　What is a medical robot? What classification does it have?

　　According to the statistics of enterprise business card data, it is found that in 2021, the highest financing amount and number of financing in the sub-sectors are service robot enterprises, followed by medical robots. Medical robots belong to the category of special service robots in service robots. They refer to semi-autonomous or fully autonomous robots that are used in medical or auxiliary medical care in hospitals and clinics. They can complete services that are beneficial to human health, but do not include production. active equipment.

　　Medical robotics is a new interdisciplinary research field that integrates medicine, biomechanics, mechanics, mechanical mechanics, materials science, computer graphics, computer vision, mathematical analysis, robotics and many other disciplines. It has a wide range of application prospects for civilian use and is a research hotspot in the field of robotics. According to the classification of the International Federation of Robotics (IFR), medical robots can be divided into four categories: surgical robots, rehabilitation robots, auxiliary robots and medical service robots.

　　Development history of China's robot market in recent years

　　The entire robot track has experienced several peaks and valleys in the development process in recent years.

　　The first funding wave peaked between the first half of 2017 and 2018.

　　The entire robotics track is actively investing, and about a dozen robotics companies have successively disclosed large-scale financing. But soon, the investment institutions at the time found that the growth and product strength of the entire robot track could not keep up, which indirectly led to the cold of the entire robot track from 2018 to 2019.

　　The peak of the second financing outbreak will occur in 2021.

　　We found that the investment and financing of the entire robotics track was very active this year. There are consecutive companies that have obtained a valuation of US$1 billion, and the 20 times PS data of the robot track company once surpassed the PS multiple of the enterprise service track.

　　Favorable national policies and epidemic factors may be an opportunity for the development of medical robots

　　When the epidemic hits in 2020, in order to start a comprehensive war against the "epidemic", medical robots play an important role in it. Since the new coronary pneumonia virus is mainly transmitted through air, contact, etc., medical robots can cut off the contact between the source of infection and medical staff from the source, thereby avoiding cross-infection. At present, the application of medical robots in the domestic new crown epidemic is mainly based on auxiliary and medical service robots.

　　Robot 365's intelligent disinfection robot performs disinfection work at the medical care site

　　On December 7, the Ministry of Industry and Information Technology of the People's Republic of China and the National Health and Health Commission jointly issued a letter, in order to promote the robot industry to better serve the development of the economy and society, a group of robots with high technical level, mature application models and significant application results were collected for the medical field. Typical scene.

　　This is closely related to the impact of the epidemic. Typical examples are medical robots. Due to the impact of the epidemic, the development is unprecedentedly rapid. According to relevant statistics, the market size of medical robots will reach 7.96 billion yuan in 2021.

　　With the development of surgical robots suitable for various medical fields and the improvement of various types of research, robot-assisted medical technology will become more and more diversified. In the future, more medical robots will be developed and commercialized. At the same time, medical robot developers who can quickly customize robot products according to the needs of different environments will occupy a leading position in the market.

　　Three factors promote the rapid development of medical robots

　　Under the double favorable factors of the country and the market, the speed of the development of medical robots has been unprecedentedly improved. The national policy orientation will continue to support the medical and health industry and continue to promote the rapid development of the entire industry. At the same time, with the increase of China's aging population, the demand for medical robots is also increasing. With the dual factors of national policy support and market demand growth, the scale of the medical market will be further expanded, and the medical robots and medical service industries will usher in new It is estimated that by 2026, the domestic medical robot market size is expected to reach 4.1 billion US dollars.

　　On the supply side, a large number of internal parts are localized, which reduces the cost of parts and leads to a decrease in the cost and selling price of medical robots. At the same time, technological breakthroughs in the core of domestic robots have also made medical robots closer to our lives.

　　Head industry capital has become the main force in the primary robot market

　　ByteDance: Frequent layout in the field of logistics robots and high investment frequency.

　　Tencent: It is not particularly active in the field of robotics, and is more optimistic about service robots in terms of investment preferences.

　　Meituan: Since last year, it has been sweeping the robot track in a large-scale, full-scenario, and systematic manner.

　　In terms of sub-sectors, the four sub-categories with the highest popularity and the largest financing scale are medical robots, distribution & cleaning robots, logistics robots and collaborative robots.

　　At present, Robot 365 has successively obtained angel investment from leading stem cell companies, Zhongxu Biology, and Xiankangda Group, and has also signed a cooperation agreement with Zhongxu Biology, Xiankangda Group, and Sino-US Saier for the "International Stem Cell Artificial Intelligence Laboratory". . In the future, these laboratories will upgrade R&D and innovation through special funds, exclusive venues, advanced equipment, and professional talents, focusing on the innovation and industrialization of stem cell industry disciplines.

　　At present, there are still some pain points and difficulties in the transformation of innovative achievements in the field of stem cell cultivation in my country, mainly due to the low degree of automation and intelligence. This cooperation will be another breakthrough and demonstration, effectively dredging the efficient cooperation model and chain of the smart medical industry.

　　Join forces to create tomorrow. After nearly two years of development, Robot 365 has successfully broken through the intelligent cultivation of stem cells through the core technology of robots. On this basis, the robot has successively developed cell culture robots, liquid pipetting and washing robots, and cryopreservation and storage robots in laboratory scenarios, realizing overall automation applications, assisting intelligent laboratory operations, and creating better medical services. equipment and conditions.